(Q86054397)
Statements
A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapy (English)
Jin Seok Ahn
Ki Hyeong Lee
Jong-Mu Sun
Keunchil Park
Eun-Suk Kang
Eun Kyung Cho
Dae Ho Lee
Sang-We Kim
Gyeong-Won Lee
Jin-Hyoung Kang
Jong-Seok Lee
Jae-Won Lee
8 September 2013